
Xovoltib 20mg Tablet
Marketer
Boehringer Ingelheim
Salt Composition
Afatinib dimaleate (20mg)
Overview Xovoltib 20mg Tablet
Azumertib 20mg tablets are indicated for treating non-small cell lung cancer in adults with specific epidermal growth factor receptor (EGFR) gene mutations. Administer this medication on an empty stomach, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician, depending on your condition and may be adjusted. Strict adherence to your doctor's prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for several weeks or months; discontinue use only as directed by your doctor. Common side effects include nausea, rash, dry skin, and diarrhea, which, if severe, requires prompt medical attention and appropriate hydration. Regular blood tests may be recommended. Photosensitivity is a possibility; utilize sunscreen and protective clothing when exposed to sunlight. Report any eye discomfort, including redness, dryness, or pain, to your physician immediately. Prior to commencing treatment, disclose any pre-existing respiratory, hepatic, or renal conditions, and all medications, including those for infections, to your physician. Interactions with other medications are possible, so comprehensive disclosure of all current medications is vital. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for women undergoing treatment.
Uses of Xovoltib 20mg Tablet
Lung cancer (excluding small cell type)
Major Benefits of Xovoltib 20mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Xovoltib 20mg Tablet whole; do not chew, crush, or divide it. Administer on an empty stomach.
Common Side effects of Xovoltib 20mg Tablet:
- Diarrhea
- Rash
- Dry skin
- Nausea
- Vomiting
- Loss of appetite
- Itching
- Stomatitis (Inflammation of the mouth)
- Nail disorder
How to use Xovoltib 20mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 20mg Xovoltib tablet whole; do not chew, crush, or fracture it. Administer on an empty stomach.
How Xovoltib 20mg Tablet works:
Xovoltib 20mg tablets are an anticancer drug that targets and blocks the EGFR, HER2, and HER4 enzyme receptors crucial for cancer cell proliferation. This inhibition disrupts their signaling pathways, thus impeding cancer growth and spread.
SAFETY ADVICE
AlcoholSAFE
Xovoltib 20mg Tablet consumption alongside alcohol presents no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Using Xovoltib 20mg tablets during pregnancy is contraindicated due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Medical advice is essential.
Breast feedingCONSULT YOUR DOCTOR
The administration of Xovoltib 20mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Xovoltib 20mg Tablet on driving ability is undetermined. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The use of Xovoltib 20mg tablets in individuals with kidney disease appears to present a low risk. Current evidence indicates dose modification may not be necessary, though this is based on limited information. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Xovoltib 20mg Tablets in patients with liver impairment is likely safe. Existing evidence indicates dose modification may not be necessary; however, physician consultation is recommended.
What if you forget to take Xovoltib 20mg Tablet :
Omit any missed dose of Xovoltib 20mg Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Xovoltib 20mg Tablet
| Label | Value |
|---|---|
| Pharmaceutical Classification | Quinazoline-based and butenamide-derived compounds |
| Potential for Dependence | None. |
| Type of Medication | Cancer-fighting drugs |
| Mechanism of Action | Kinase inhibitors targeting tyrosine |
